Skip to main content

Table 2 Summary of baseline and post-intervention systemic sex steroid hormones and estrogen metabolites (n = 34)

From: A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones

Sex steroid hormones Baseline Post-intervention % change P b
Estradiol, pg/ml 12.3 ± 20.7a 15.5 ± 34.9 22.4 ± 178 0.47
Estrone, pg/ml 26.1 ± 12.7 25.8 ± 14.3 1.4 ± 38.3 0.83
Testosterone, ng/ml 0.18 ± 0.11 0.18 ± 0.12 −0.85 ± 27.2 0.86
SHBG, nmol/L 42.1 ± 17.6 45.3 ± 18.0 10.0 ± 17.8 <0.01
2-OHE1, ng/mg creatinine 9.5 ± 8.8 13.8 ± 8.75 73.2 ± 132 <0.01
16α-OHE1, ng/mg creatinine 6.6 ± 6.1 6.6 ± 3.0 15.9 ± 51.0 0.08
2-OHE1/16α-OHE1 ratio 1.7 ± 1.4 2.7 ± 2.7 84.5 ± 175 <0.01
  1. aData are presented as mean ± SD.
  2. bDerived from a paired t-test for % change from baseline to post-intervention.